Table 2.
Cocaine discrimination accuracy at criteria and dose-effect curve
Genotype | %DAR saline | %DAR cocaine | A50 DAR | A50 rate reduction |
---|---|---|---|---|
Wild-type | 1.9 ± 0.6 | 98.6 ± 0.5 | 1.49 [1.04 – 2.14] | 9.77 [8.22 – 11.6] |
M1−/− | 1.0 ± 0.6 | 97.4 ± 0.8 | 2.05 [1.23 – 3.43] | 11.8 [7.42 – 16.6] |
M4−/− | 1.2 ± 0.4 | 98.6 ± 0.7 | 1.49 [0.69 – 3.19] | 10.3 [6.42 – 16.5] |
%DAR saline and %DAR cocaine represent average performance over the block of sessions that satisfied discrimination criteria (group means ± s.e.m.). Group sizes: wild-type, N = 13, M1−/−, N = 9, M4−/− mice, N = 8. Reductions in response rates by at least 50% were not observed in all of the subjects, and A50 for rate reduction was calculated from 12 wild-type mice, 5 M1−/− mice, and 6 M4−/− mice.